O'Reilly Automotive vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Springfield MO auto parts retail (NASDAQ: ORLY) at record $16.71B FY2024 sales (+6%); 32 consecutive years comp growth, 6,200+ stores, professional + DIY dual-market competing with AutoZone and Advance Auto.
About
O'Reilly Automotive, Inc. is a Springfield, Missouri-based specialty retailer and supplier of automotive aftermarket parts, tools, supplies, equipment, and accessories — publicly traded on NASDAQ (NASDAQ: ORLY) as an S&P 500 Consumer Discretionary component — operating approximately 6,200 stores across 48 states, Puerto Rico, Canada, and Mexico, serving both do-it-yourself (DIY) consumers who repair their own vehicles and professional service providers (DIFM, Do-It-For-Me — auto repair shops, body shops, dealerships) through approximately 89,000 team members. In fiscal year 2024, O'Reilly reported record full-year sales of $16.71 billion (+6% year-over-year) and net income of $2.39 billion (+2%), marking 32 consecutive years of comparable store sales growth — an unbroken streak through multiple recessions, pandemic disruptions, and consumer spending cycles. Fourth quarter comparable store sales grew 4.4% driven by solid growth in both professional and DIY segments, with 198 net new stores opened during 2024. CEO Brad Beckham, who took over in March 2023 from Greg Johnson, continues the operational discipline that has made O'Reilly the most consistently profitable auto parts retailer in the US — maintaining the dual-market strategy that simultaneously serves professional mechanics who need parts immediately (same-day delivery from O'Reilly's 200+ distribution centers to the repair shop) and weekend DIY customers who replace their own brakes, oil filters, and batteries with O'Reilly team member assistance.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.